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Abstract
Background: Obesity is a major risk factor for hypertension, however, the physiologic mechanisms linking increased
adiposity to elevations in blood pressure are not well described. An increase in resting energy expenditure (REE) is an
obligatory consequence of obesity. Previous survey research has demonstrated that REE is an independent predictor of
blood pressure, and eliminates the co-linear association of body mass index. This observation has received little
attention and there have been no attempts to provide a causal explanation.
Methods: At baseline in an international comparative study on obesity, 289 participants aged 25–44 were recruited
from communities in the US, the Seychelles, Ghana and South Africa and had REE measured with indirect calorimetry.
All participants were thought to be free of major illness.
Results: In multivariate regression models, both systolic and diastolic blood pressure were positively associated with
REE (p < 0.01), while body mass index and fat mass were negatively correlated with systolic blood pressure (p < 0.01,
and p < 0.05 respectively), but not diastolic blood pressure.
Conclusions: These data confirm previous reports and suggest that a common physiologic abnormality links REE and
blood pressure. Elevated catecholamines, a putative metabolic characteristic of obesity, is a possible candidate to
explain this association. The direct role of excess adipose tissue is open to question.
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Background
Resting energy expenditure (REE) accounts for 70–
80% of total daily energy expenditure and is tightly
regulated, exhibiting relatively little variation within
an individual over time. Epidemiologic survey re-
search on the inter-relationship of REE with traits in-
volved in the cardiovascular metabolic risk pattern
and other chronic diseases has been focused primarily
on the potential relationship with obesity [1]. The
majority of energy required in the resting state is de-
voted to protein synthesis and maintenance of the
electro-chemical gradient across cell membranes [2].
As a consequence, REE is highly correlated with lean
body mass although it can be up-regulated by
increases in circulating thyroxin and catecholamines
[3–5]. REE also responds to variation in energy
intake, for example, during periods of sustained fast-
ing REE declines to compensate for lower energy in-
take along with profound changes in the hormone
milieu [6].
Because of its important role in the energy budget,
inter-individual variation in REE has been examined
extensively as a potential contributor to susceptibility to
obesity. A series of widely cited studies conducted
among the Pima Indians in the US Southwest has
reported a significant negative correlation between REE
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and risk of obesity [7, 8]. However, our group found
equivalent REE levels after adjustment for body size and
composition in a study comparing African-Americans
and rural Nigerians, and no relationship to risk of fu-
ture weight gain [9]. This null REE-obesity association
is consistent with previously reported research finding
no effect for either REE, or sleeping EE, for future
weight gain among obesity-resistant or obesity-prone
women [10, 11].
As a measure of metabolic activity in the resting
state, it is reasonable to speculate that a range of
systemic metabolic functions might be influenced by,
or associated with, REE [12]. In a previous report, we
identified a strong relationship between REE and
blood pressure (BP) after controlling for measures of
body size and composition in population-based
samples in the US and Nigeria [13]. This relationship
has also been described in a case-control study of
obese and non-obese individuals [14], as well as in in-
digenous Siberians [15]. A recent report found after
4.5 years of follow-up in healthy, overweight African
American and white women, that REE was a signifi-
cant predictor of systolic blood pressure, independent
of adiposity [12].
Adiposity has long been recognized as a risk factor for
hypertension [13, 16, 17]. However, the underlying
physiological mechanisms that link excess body fat
stores to BP are poorly understood [13]. Obesity is a
highly complex syndrome that is a consequence of meta-
bolic alterations and lifestyle patterns that include, but
are not limited to, insulin resistance, hyper-leptinemia,
elevated BP, a high-calorie/high-sodium intake and
reduced physical activity [13, 18]. Co-linearity of these
relationships makes it difficult to isolate specific causal
effects. For example, sodium intake is associated with BP
in cross-sectional studies, although the effect is reduced
or eliminated by control for body mass index (BMI)
[19]. The increased energy intake among the obese
makes higher salt consumption obligatory; whether
control for BMI is “over-control” is therefore an open
question [20]. Abnormalities in the renin-angiotensin
system and increased levels of various regulatory
hormones, like insulin and leptin, have been consistently
described to take place among the obese, although the
causal link to hypertension is tenuous. A number of
other metabolic abnormalities, have been reported
among obese vs. non-obese hypertensive individuals,
although these associations are relatively inconsistent [13,
21]. Generally, it is assumed that body mass itself, driven
largely by the size of body fat stores, is the primary deter-
minant of hypertension risk. However, it must be recog-
nized that an obligatory increase in lean body mass occurs
in parallel with total body weight, which in the general
population is highly correlated with fat mass [13, 21].
As part of an international comparative study of the
evolution cardio-metabolic risk factors, we have been
investigating the effects of energy expenditure and
obesity on BP in populations of the African diaspora.
Using community-based samples in Nigeria, Jamaica,
and the United States, we previously demonstrated that
metabolic processes represented by REE appear to medi-
ate the effect of body size on BP [13]. In the current
study, we aimed to confirm that finding in four add-
itional independent population samples in the African
diaspora. In this second phase the community-based
samples were also drawn from a wide spectrum of social
and cultural contexts. The findings reported here
strongly confirm the association between REE and BP.
Methods
Participant recruitment
The Modeling the Epidemiologic Transition Study
(METS) is an international comparative study investigat-
ing the associations between physical activity and diet,
and weight gain in young African-origin adults (25–
45 years) [22–25]. A very detailed description of the
study protocol has been previously published [26]. At
baseline; twenty-five hundred adults were enrolled be-
tween January 2010 and December 2011. Five hundred
participants, about 50% female, were recruited from each
of the five sites of interest: rural Ghana, urban South
Africa, Seychelles, urban Jamaica, and metropolitan
Chicago [26]. The current analysis included a sub-set of
participants with valid REE and BP measurements;
participants from Jamaica were not included in these
analyses due to lack of valid REE measurements.
Participants were excluded from the study if they had or
developed any infectious diseases, including HIV-
positive individuals, pregnant or lactating women, and
people with conditions preventing them from participat-
ing in normal physical activities [27].
METS protocol was approved by the Institutional Review
Board of Loyola University Chicago, IL, US; the Committee
of Human Research Publication and Ethics of Kwame
Nkrumah University of Science and Technology, Kumasi,
Ghana; the Health Sciences Faculty Research Ethics
Committee of the University of Cape Town, South Africa;
the Board for Ethics and Clinical Research of the University
of Lausanne, Switzerland; the National Research Ethics
Committee of Seychelles; and the Health Sciences
Institutional Review Board of the University of Wisconsin,
Madison, WI, USA. Written informed consent was obtained
from all participants [26].
Measurements
Measurements were gathered at outpatient clinics located
in the respective communities. BP measurements were
performed by trained and certified observers, according to
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standard procedures, and as previously described [28].
Briefly, measurements were made in the sitting position,
with the arm at heart level after a 5-min rest [26]. An
oscillometric device, previously evaluated in our field
settings, was used for all BP measurements (Omrom
HEM-412). A total of six measurements were performed.
Initially three measurements were taken 3 min apart, and
a further three measurements were repeated 1 h later, also
following a 5-min rest period. For the analysis, BP was
calculated as the average of 4 measurements; 2, 3, 5, and 6
[26]. Weight (kg) and height (m) measurements were
performed while participants wore light clothing and
no shoes, and according to the same procedures
across the 5 sites, including identical stadiometer’s
(Invicta, Germany), and using the same model stand-
ard calibrated balance at all five sites (Seca 770,
Hamburg, Germany) [26]. BMI was calculated as kg/m2.
Body composition was approximated by bioelectrical im-
pedance analysis (BIA) with the use of a single-frequency
(50 kHz) impedance analyzer (model BIA 101Q; RJL
Systems, Clinton Township, MI), using a tetrapolar place-
ment of electrodes was used on the right hand and foot.
Fat-free mass (FFM) and fat mass (FM) were estimated
from measured resistance by using an equation validated
in the METS cohorts [29].
Body composition (isotope dilution)
Total body water was measured using isotope dilution
in a subset of 75 participants at baseline in each site,
and as previously described [26, 30]. The basis of this
measurement is the dilution principle: total body
water was calculated using the measurement of the
abundance of either isotope (deuterium or 18-oxygen)
from a doubly labeled water (DLW) procedure after
complete equilibration with body water [31] and cor-
rection for non-aqueous exchange of 1.042 and 1.007,
respectively [32]. Fat-free mass was calculated using a
hydration constant (0.732 [33]) from total body water,
and fat was calculated as the difference between body
weight and fat-free mass [34].
Resting energy expenditure
REE was measured in the DLW subsample using indir-
ect calorimetry [26]. In the US, Ghana, and Seychelles
sites, REE was measured using the Cosmed Quark RMR
indirect calorimeter (Cosmed USA, Chicago, IL, USA);
and in South Africa, the VMax indirect calorimeter by
SensorMedics (Viasys Health Care, Waukegan, IL, USA)
was used. Cross-validation of instruments was carried
out through external calibrations. The investigators have
had extensive experience in the measurement of REE
across multiple sites, with over 2500 measurements
made in the US and abroad [9, 35, 36].
The detailed description of measurement of REE
using indirect calorimetry has been previously pub-
lished [35–37]. Participants were asked to fast from
10 pm the evening prior to the initial examination
and were rested for at least 15 min prior to the REE
measurement. Respiratory gases were collected for
30 min, the first 10 min of data were discarded and
last 20 min used to estimate REE. Oxygen and carbon
dioxide were continuously sampled during the
procedure and minute-by-minute consumption and
production values were calculated; energy expenditure
was calculated according to the modified Weir
equation [38]. REE data were available for 289
participants.
Physical activity (accelerometer)
Physical activity (PA) was measured using the Actical ac-
celerometer (Phillips Respironics, Ben, OR, USA), and as
previously described [26]. Briefly, participants wore the
monitor at the level of the waist, positioned just behind
the right hip [26]. All participants were asked to wear
the activity monitor at all times over an 8-day period
encompassing part of the first and last days the monitor
was worn, and to not take the monitor off during sleep.
Using the same protocol employed by the National
Center for Health Statistics for the analysis of accelero-
metry data in the continuous National Health and
Nutrition Examination Survey [39], minutes were
defined as comprising sedentary (<100 counts per mi-
nute [cpm]), moderate (1535–3959 cpm), vigorous
≥3960 cpm or a combination of moderate-plus-vigorous
activity, using published cut-points [40, 41]. PA data are
presented as the total time in minutes accumulated in
either 1- or 10- min intervals; the 10-min interval may
be considered a modified 10-min bout as we allowed for
up to 2 min of below threshold count activity before
considering the bout to be ended [39].
Biochemical measures
Participants were asked to fast from the evening prior to
the baseline clinic examination, and as previously
described [26]. Fasting blood samples were drawn for ana-
lysis of adipose-related hormones (leptin, adiponectin)
and other analytes (glucose and insulin). Briefly, blood
samples were processed and plasma or serum separated
within two hours of collection and stored at −80 °C in the
laboratory at each study site [26]. Fasting plasma glucose
was measured using the glucose oxidase method at each
site at the time of collection. Insulin, leptin and adiponec-
tin from all sites were measured using radioimmunoassay
kits at the departmental laboratory at Loyola University
Chicago (Linco Research, Inc., St. Charles, MO). All
remaining assays were conducted at the Zentrum fϋr
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Lambormedizin, Leiter Klinische Chemie und Hämatologie,
St. Gallen, Switzerland.
Questionnaires
All questionnaires were administered by centrally trained
personnel, and as previously described [26]. These in-
cluded necessary health history information, with a focus
on cardiovascular disease (CVD) conditions and diabetes.
Information included age of first diagnosis where applic-
able, and medication and dietary supplement use.
In total, 54 additional questions were included which
covered general household characteristics, participant
and significant other’s occupation, parental education
and household assets and amenities, and as previously
described [26]. These questions were based on the Core
Welfare Indicators Questionnaire from the World Bank,
designed to monitor social indicators in the Human
Development Index (HDI) contexts [42].
Loyola University Chicago (Chicago, IL, USA) is the
centralized coordinating center for METS [26], Briefly,
all data forms, including the questionnaires were
scanned at each study site and along with electronic
Actical data files, sent via secure FTP (Bitvise Tunnelier
[43]) to the data manager at the coordinating center.
Statistical analysis
Participant characteristics were summarized using
means ± standard deviations (SD) and proportions. For
hypothesis testing of continuous variables we employed
a two-way Anova with Bonferroni correction, multiple
linear regression analysis, using dummy variables for site
and Pearson’s Correlation Coefficient. For categorical
variables, we used the Chi-Square statistic. An alpha
p-value of 0.05 was used to denote statistical signifi-
cance. The statistical analyses was performed using Stata
(version 12, College Station, TX).
Results
For the present study, the analytical data set included all
participants who underwent REE and body composition
measurements at the same time, and had valid BP mea-
surements. The final sample included 289 participants of
which 69 were from Ghana, 72 from South Africa and
72 from Seychelles, and 76 from the US.
Baseline participant characteristics are presented in
Table 1. Women were slightly older than men (33.6 ± 5.9
vs. 35.0 ± 6.0 yrs., p < 0.05), and at all sites had on aver-
age higher BMI than men and in all but 1 site weighed
more than men. As expected, men had higher mean fat
Table 1 Participant Characteristics by Site: Mean ± SD
Ghana South Africa Seychelles United States
Men
Age (y) 35.6 ± 6.1 33.0 ± 6.2 33.4 ± 5.3 32.9 ± 5.8
Weight (kg) 62.4 ± 7.1** 62.5 ± 12.6** 73.0 ± 11.2* 90.9 ± 24.2
Fat Free Mass (kg) 53.6 ± 5.9** 47.4 ± 7.1** 55.2 ± 5.6 63.7 ± 10.1
Body Fat (%) 14.4 ± 5.2 23.4 ± 6.1 23.3 ± 9.0 27.6 ± 11.8
Body Mass Index (kg/m^2) 22.0 ± 2.3** 22.1 ± 4.1** 25.2 ± 3.6* 28.5 ± 7.7
Systolic Blood Pressure (mmHg) 116.8 ± 10.5** 121.1 ± 20.6 119.4 ± 13.4 128.7 ± 14.0
Diastolic Blood Pressure (mmHg) 66.7 ± 10.1** 72.0 ± 14.1* 71.7 ± 10.7** 80.9 ± 9.7
Resting hear rate (bpm) 63.2 ± 8.0 62.0 ± 6.8 60.5 ± 8.3 61.3 ± 8.4
Resting Energy Expenditure (kcal/day) 1618 ± 136 1528 ± 202** 1651 ± 170 1768 ± 371
MVPA (min/day) 60.0 ± 23.1* 52.5 ± 25.4 49.2 ± 31.1 38.9 ± 33.1
Women
Age (y) 37.4 ± 6 34.2 ± 6.0 32.1 ± 6.3** 34.3 ± 5.8
Weight (kg) 63.2 ± 15.9** 83.9 ± 26.4 75.8 ± 18.6* 88.9 ± 18.6
Fat Free Mass (kg) 41.3 ± 6.6** 45.6 ± 8.5 43.6 ± 6.6 49.3 ± 7.3
Body Fat (%) 32.9 ± 9.3 43.2 ± 10.3 41.0 ± 7.6 43.1 ± 10.8
Body Mass Index (kg/m^2) 25.4 ± 7.0** 33.0 ± 9.4 28.4 ± 6.2* 33.2 ± 7.4
Systolic Blood Pressure (mmHg) 105.6 ± 12.8** 116.5 ± 19.7 105.2 ± 8.5** 117.8 ± 16.7
Diastolic Blood Pressure (mmHg) 63.0 ± 11.2** 73.0 ± 12.6** 69.7 ± 7.6** 81.5 ± 13.3
Resting heart rate (bpm) 73.6 ± 8.8 72.7 ± 11.0 68.9 ± 7.5 70. ± 9.5
Resting Energy Expenditure (kcal/day) 1389 ± 167 1550 ± 232 1404 ± 190 1439 ± 294
MVPA (min/day) 26.7 ± 17.3 18.6 ± 16.1 20.4 ± 12.9 18.3 ± 21.9
*p < 0.05 compared to US, **p < 0.01 compared to the US
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free mass levels. Men also had higher mean systolic and dia-
stolic BP measurements. The mean systolic BP (SBP) among
men was 121.9 ± 15.4 mmHg, and among women was 111.4
± 16.2 mmHg. The mean diastolic BP (DBP) among men
was 73.3 ± 12.2 mmHg, and among women was 71.8 mmHg.
Men and women from the US, and South Africa presented
with the highest SBP and DBP’s. Women presented with
higher resting pulse values (p < 0.001), but which were
similar across sites among both men and women (p=NS).
With regards to PA levels, across all sites, participants spent
approximately 33.9 ± 27.7 min/d in moderate-and-vigorous
activity (1-min bouts), very little time doing any vigorous
activity (3.4 ± 6.8 min/d) and approximately 4 h a day being
sedentary (228.5 ± 50.8 min/d).
Biochemical results are presented in Table 2. The ma-
jority of participants presented with healthy biochemical
measures. The mean glucose levels across all sites were
93.2 ± 19.1 mg/dL, with participants in Ghana presenting
with the highest values (100.6 ± 9.7 mg/dL). Mean
insulin levels were 17.6 ± 10.5 mlU/L and lowest among
the Ghanaians (13.7 ± 6.0 mlU/L). CRP values were high-
est among the 2 African sites, compared to the US and
Seychelles, whereas measures of lipid metabolism were
lowest among South Africans and Ghanaians.
Data concerning participants’ medical background and
behaviors are presented in Table 3. Overall, 12.8% of the
participant sample had hypertension. Among men; 24%
of Americans were hypertensive compared to 18% for
Seychellois, 11% for South Africa and only 3% among
Ghanaians (p = 0.094). Similarly, 24% of US women were
hypertensive compared to 16% of South Africans, 3% of
Seychellois and Ghanaian women (p < 0.01). 45.7% of the
participant population met the U.S. General Guidelines
for PA. As expected, a significantly higher percentage of
men met the U.S. General Guidelines than women (65
vs. 35%, p < 0.001). 31.6% of the participant sample
indicated that they smoke, with more men indicating
that they smoked compared to women (45.4 vs. 14.5%).
Approximately 46.7% of the participant population re-
ported that they consumed alcohol, with twice as many
men indicating alcohol consumption than women (64.6
vs. 32.1%). Men on average reported consuming 1.8 ±
3.0 units/day and women reported 0.68 ± 1.7 units/day.
Partial correlations were examined between REE, SBP,
DBP, pulse, weight, fat-free mass, and age for men and
women and are represented in Table 4. Among men, REE
(kcal/d) was significantly correlated with both SBP and DBP
(mmHg), weight (kg), fat free mass (kg) and the adipokines
Table 2 Participant Biochemical Measures by Site, mean ± SD
Ghana South Africa Seychelles United States
Men
Glucose (mg/dL) 102.5 ± 10.0 83.1 ± 16.1** 98.4 ± 13.9 95.8 ± 11.9
Insulin (μIU/mL) 11.7 ± 3.8* 11.2 ± 5.2* 14.5 ± 6.7 17.4 ± 12.9
HOMA-IR 2.9 ± 0.9 2.3 ± 1.3** 3.6 ± 1.9 4.3 ± 3.5
Leptin (ng/mL) 5.2 ± 5.3 5.6 ± 5.1 8.4 ± 7.4 10.8 ± 13.8
Adiponectin (ng/mL) 9677.3 ± 4042.9 9854.9 ± 4211.3 5590.3 ± 2863.7* 8544.0 ± 4651.7
CRP (mg/L) 4.3 ± 11.4 2.7 ± 3.8 1.5 ± 1.2 2.2 ± 2.3
Total cholesterol (mg/dL) 159.5 ± 40.6 171.1 ± 40.3 164.2 ± 39.4 175.2 ± 35.4
LDL cholesterol (mg/dL) 93.8 30.1 97.9 ± 32.4 89.5 ± 27.8 105.6 ± 33.3
HDL cholesterol (mg/dL) 47.3 ± 21.7 58.0 ± 25.2 54.1 ± 14.3 50.5 ± 13.5
Triglycerides (mg/dL) 90.3 ± 38.4 94.3 ± 43.9 75.7 ± 40.7 96.1 ± 58.4
Women
Glucose (mg/dL) 98.9 ± 9.2 83.7 ± 15.5 89.4 ± 18.7 95.4 ± 34.5
Insulin (μIU/mL) 15.3 ± 7.0** 22.4 ± 13.7 19.6 ± 9.0 24.4 ± 14.3
HOMA-IR 3.7 ± 1.9* 4.8 ± 3.5 4.3 ± 2.4 5.7 ± 3.7
Leptin (ng/mL) 30.7 ± 25.6 37.0 ± 26.7 39.4 ± 24.1 41.5 ± 20.1
Adiponectin (ng/mL) 10,352.1 ± 4502.9 11,595.5 ± 6222.8 8005.7 ± 5134.3 9461.5 ± 5389.5
CRP (mg/L) 7.6 ± 20.0 12.5 ± 17.5 5.2 ± 5.3 5.5 ± 4.6
Total cholesterol (mg/dL) 164.0 ± 33.0* 157.0 ± 31.1** 169.0 ± 34.5 187.6 ± 36.7
LDL cholesterol (mg/dL) 102.3 ± 28.3 96.4 ± 30.0* 106.8 ± 38.0 119.0 ± 37.2
HDL cholesterol (mg/dL) 44.6 ± 11.7 45.1 ± 15.2 48.4 ± 8.6 49.7 ± 13.0
Triglycerides (mg/dL) 86.7 ± 39.5 78.5 ± 17.5 63.9 ± 43.2* 96.7 ± 56.5
*p < 0.05 compared to the US, **p < 0.01 compared to the US
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(leptin and adiponectin). Similarly, among women, REE was
significantly correlated with the same variables, and addition-
ally pulse (bpm), but not adiponectin.
Multiple regression analyses were conducted to deter-
mine relationships between BP and REE, age, gender,
body mass index, fat free and fat mass, resting pulse,
and location of site. We present two models, Model 1
included BMI, and Model 2 included fat and fat free
mass levels. These results are shown in Table 5. For
Model 1, after adjusting for BMI, age, gender, pulse, and
site, having higher REE (kcal/d) was significantly
associated with greater systolic BP (β = 0.019, p = 0.001)
and strongly associated with diastolic BP (β = 0.006,
p = 0.056) BP (mmHg). Similarly, adjusting for fat
and fat free mass, instead of BMI, indicated that
those with higher REE (kcal/d) also had significantly
higher systolic BP (β = 0.019, p = 0.001) and a strong
association with diastolic BP (β = 0.007, p = 0.056).
Discussion
In this report, we found an independent association be-
tween REE and BP among five populations with different
mean BP levels. As noted earlier, the obesity syndrome
should be conceptualized as a complex, inter-correlated set
of external exposures and internal physiologic responses
[13, 18]. Separating cause of effect relationships is therefore
inherently difficult. Our findings suggest that the measure
of REE captures a physiologic process more tightly associ-
ated with BP than basic estimates of weight-for-height, as
modeled by BMI. The most likely candidate linking REE
with BP is circulating catecholamines [44]. Although incon-
sistent, a substantial body of literature has demonstrated el-
evated catecholamines in hypertensive subjects [45–47].
Some investigators have likewise argued that increased
sympathetic activity secondary to hyperinsulinemia is a
feature of the obesity syndrome [48, 49]. Palatini
et al. [50] found that among 3 international adult co-
horts, fasting insulin and post 75-g glucose load cor-
related positively with higher heart rates. There is
also some evidence that obese adults are more likely
to present with increased urinary noradrenaline levels
[51] and plasma levels [52]. Weight loss studies pro-
vide evidence supporting the catecholamine hypoth-
esis in obesity. Among twenty-five obese individuals
studied during a short-term weight loss intervention,
a reduction in plasma norepinephrine was closely as-
sociated with reductions in REE and BP [14]. Leptin
has also been associated with thermogenesis and
hypertension and is markedly elevated in the obese
[53]. While not a significant predictor in the current
study, the role of other inflammation markers such as
CRP has also been cited as a significant predictor of
future CVD. For example, several studies find a rela-
tionship between adipocytokines, CRP and risk for
CVD [54, 55]. Seven et al. [54] explored the relation-
ship between leptin, adiponectin, CRP and risk for
CVD in over 6500 adults (30-60 yrs). After 11 years
of follow-up only CRP was found to be significantly
associated with an increased CVD risk. Similarly,
Barbero et al. [55] in a meta-analysis of almost
105,000 adults followed for 5 years, found that CRP,
together with history of diabetes, past myocardial in-
farction, and being male were the most significant
predictors for future CVD.
In attempting to disentangle correlated physiologic
relationships, it can be useful to consider contextual patterns
to determine whether they support or contradict the specific
hypothesis being examined. REE would require increased
cardiac output, which in the long-term could predispose to
hypertension [56, 57]. For example, catecholamines increase
Table 3 Participant Categorical Data - n, %
Ghana South Africa Seychelles United States p-value
Men
Overweight/Obese 28 (90.32) 23 (82.14) 17 (51.52) 18 (47.37) 0.001
Hypertension 1 (3.23) 3 (10.71) 6 (18.18) 9 (23.68) 0.094
Meets PA Guidelines 27 (87.10) 22 (78.57) 23 (69.70) 21 (55.26) 0.025
Smoker 0 (0.00) 18 (58.10) 8 (24.24) 24 (63.16) 0.001
Drinker 12 (38.71) 19 (67.86) 27 (81.82) 26 (68.42) 0.003
Women
Overweight/Obese 22 (57.89) 14 (31.82) 11 (28.21) 4 (10.53) 0.001
Hypertension 1 (2.63) 7 (15.91) 1 (2.56) 9 (23.68) 0.006
Meets PA Guidelines 17 (44.74) 8 (18.18) 14 (35.90) 9 (23.68) 0.042
Smoker 0 (0.00) 6 (13.64) 1 (2.56) 13 (34.21) 0.001
Drinker 3 (7.89) 12 (27.27) 22 (56.41) 14 (36.84) 0.001
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with age, as does BP, and elevated heart rate has long been
recognized as a predictor of hypertension [56]. Physical activ-
ity and training effects, however, are inconsistent with a
straightforward causal link between REE and BP. REE tends
to increase with aerobic fitness, while BP and pulse rate de-
cline [58, 59]. Likewise, weight lifters and other athletes have
marked increases in lean body mass, but avoid the obesity-
related effect of high BP [60]. We have also demonstrated
that the association between BMI and BP is weaker among
the obese than the non-obese, suggesting that lean body
mass is the more influential component of total body size
[61]. It is nonetheless possible that a catecholamine-
mediated effect that leads to increases in both REE and BP,
could be over-ridden by other compensatory mechanisms
after aerobic training. A simpler non-mechanistic explan-
ation of why REE remains significantly associated with BP in
our analyses, and BMI is not, could be a result of differential
precision of the measurements. BMI captures about 40–50%
Table 4 Partial Correlations between REE, Age, Systolic and Diastolic BP, resting heart rate (HR), Weight, Fat Free Mass, and
Adipokines for Men and Women (P Values)
Men
REE Age SBP DBP Pulse Weight FFM Insulin Leptin Adiponectin
REE
Age −0.0065 (0.9415)
SBP 0.2666
(0.0022)
0.1860
(0.342)
DBP 0.2570
(0.0032)
0.1950
(0.0262)
0.8661
(0.0000)
Resting HR 0.1263
(0.1521)
0.0993
(0.2609)
0.0242
(0.7843)
0.1849
(0.0352)
Weight 0.7069
(0.0000)
0.0615
(0.4873)
0.2596
(0.0029)
0.3813
(0.0000)
0.0336
(0.7040)
FFM 0.6755
(0.0000)
0.0374
(0.6731)
0.1810
(0.0393)
0.2064
(0.0185)
−0.0420
(0.6355)
0.8431
(0.0000)
Insulin 0.3479
(0.0001)
0.0827
(0.3555)
0.1388
(0.1198)
0.2532
(0.0041)
0.1417
(0.1121)
0.3674
(0.0000)
0.2214
(0.0123)
Leptin 0.4426
(0.0000)
0.0621
(0.4843
0.1135
(0.2001)
0.2522
(0.0039)
0.1236
(0.1628)
0.7313
(0.0000)
0.4841
(0.0000)
0.3631
(0.0000)
Adiponectin −0.2115
(0.0157)
0.1146
(0.1943)
0.0190
(0.8299)
−0.0714
(0.4194)
−0.0949
(0.2829)
−0.2330
(0.0076)
−0.1282
(0.1462
−0.2857
(0.0011)
−0.2351
(0.00073
Women
REE Age SBP DBP Pulse Weight FFM Insulin Leptin Adiponectin
REE
Age 0.0262 (0.7426)
SBP 0.2023
(0.0105)
0.2674
(0.0007)
DBP 0.2475
(0.0017)
0.1817
(0.0219)
0.8451
(0.0000)
Resting HR 0.2234
(0.0047)
−0.0634
(0.4269)
−0.0413
(0.6050)
0.0435
(0.5858)
Weight 0.6264
(0.0000)
0.0155
(0.8461)
0.1298
(0.1030)
0.3597
(0.0000)
0.0447
(0.5762)
FFM 0.6701
(0.0000)
0.0248
(0.7567)
0.2140
(0.0068)
0.3287
(0.0000)
0.0182
(0.8202)
0.8058
(0.0000)
Insulin 0.4378
(0.0000)
−0.0699
(0.3893)
0.0408
(0.6153)
0.2691
(0.0007)
0.1947
(0.0155)
0.6333
(0.0000)
0.4727
(0.0000)
Leptin 0.3230
(0.0000)
−0.0354
(0.6625)
−0.1160
(0.1518)
0.1135
(0.1612)
0.0833
(0.3044)
0.7069
(0.0000)
0.4264
(0.0000)
0.4841
(0.0000)
Adiponectin −0.1556
(0.0539)
0.1171
(0.1482)
0.0344
(0.6717)
−0.1089
(0.1788)
−0.0150
(0.8537)
−0.2852
(0.0003)
−0.2643
(0.0009)
−0.3284
(0.0000)
−0.2069
(0.0100)
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of the variation in lean body mass, while repeat REE
measurements for that person have a correlation of
0.95, reflecting very high precision. In multivariate
models, a secondary variable measured with little
error can achieve significance “independently” of the
underlying causal effect, particularly if other covari-
ates in the model, which may have a true causal link
with the outcome, lack precision.
In our study, while we attempted to ensure consistency
and reliability of measurements, particularly with regards to
the measurement of BP and REE across our research sites,
our study is not without limitations. For example, we have
no measure of circulating catecholamines, an issue which we
have now addressed in our current studies. In order to
maximize comparability of REE measurements we used the
same indirect calorimeter in three of the four research sites,
and conducted regular methanol burns as described by
Cooper et al. [62]. With regards to the measurement of BP,
the same model Omron was used in all sites and all clinic
staff underwent the same in-house training prior to the start
of the data collection period, and as previously described by
Luke et al. [26]. Due to the nature of multi-site research,
there is always the potential for site-to-site variability in some
measures. The investigators of the current study worked
hard to minimize that variability.
Conclusion
In summary, our study provides further evidence of a
strong association between REE and BP, and a null or
modest role of BMI or other adiposity measures on BP
when REE is considered, which has not been fully
appreciated so far. These findings expand our under-
standing of the complex of metabolic and physiologic
abnormalities observed in the obesity syndrome.
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